Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Times Interest Earned (2016 - 2025)

Protalix BioTherapeutics (PLX) has 13 years of Times Interest Earned data on record, last reported at -$690.83 in Q1 2025.

  • For Q1 2025, Times Interest Earned fell 5448.29% year-over-year to -$690.83; the TTM value through Sep 2025 reached $135.47, up 1477.97%, while the annual FY2024 figure was $3.69, 551.97% up from the prior year.
  • Times Interest Earned reached -$690.83 in Q1 2025 per PLX's latest filing, down from $175.83 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $175.83 in Q4 2024 and bottomed at -$690.83 in Q1 2025.
  • Average Times Interest Earned over 5 years is -$32.17, with a median of -$3.84 recorded in 2022.
  • Peak YoY movement for Times Interest Earned: skyrocketed 1043.44% in 2024, then crashed 5448.29% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $9.87 in 2021, then crashed by 138.88% to -$3.84 in 2022, then crashed by 385.54% to -$18.64 in 2023, then surged by 1043.44% to $175.83 in 2024, then crashed by 492.9% to -$690.83 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$690.83 in Q1 2025, $175.83 in Q4 2024, and $15.35 in Q3 2024.